Quarterly report [Sections 13 or 15(d)]

LIQUIDITY (Details Narrative)

v3.26.3
LIQUIDITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Jun. 17, 2026
Feb. 26, 2026
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Subsidiary, Sale of Stock [Line Items]              
Net loss     $ 864,264 $ (1,040,254) $ 45,216,449 $ (6,637,948)  
Cash used in operating activities         779,166    
Working capital surplus     105,547,985   105,547,985    
Accumulated deficit     38,986,591   38,986,591   $ 84,203,040
Gross proceeds from pre-funded warrants $ 55,000,000            
Cash     44,805,403   44,805,403   $ 15,472,229
Working capital deficit     49,500,000   49,500,000    
Deferred purchase consideration due     $ 42,900,000   $ 42,900,000    
IPO [Member]              
Subsidiary, Sale of Stock [Line Items]              
Proceeds from issuance of public offering   $ 65,000,000